abstract |
The present invention is directed to methods, compounds, and compositions for transporting 1,3-propanedisulfonic acid (1,3PDS) in a subject, preferably a human subject. The present invention is in vitro ( in vitro) or in vivo (in in vivo ) encompasses compounds that will yield or produce 1,3PDS. The present invention also relates to sulfonate ester prodrugs of 1,3PDS and gemini dimers and oligomers of 1,3PDS for the prevention and treatment of associated diseases and conditions. |